The gastrin-releasing (GRPR) peptide reduces hippocampal CA1 neuron excitability by enhancing inhibitory synaptic transmission, offering insight into its role in improving cognition and treating CNS disorders [94]. Here, GRPR is linked to central nervous system disorder.